RIGL · Categories · Form 4

RIGL - SEC Form 4 insider transactions

Rigel Pharmaceuticals Inc. (RIGL) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for RIGL

• 6d
  EVP & Chief Financial Officer Schorno Dean L exercised 3,381 shares at a strike of $14.83 and covered exercise/tax liability with 928 shares, increasing direct ownership by 3% to 78,790 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 6d
  EVP, Chief Commercial Officer Santos David A covered exercise/tax liability with 874 shares, decreasing direct ownership by 1% to 61,996 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 6d
  EVP, Chief Medical Officer Rojkjaer Lisa covered exercise/tax liability with 850 shares, decreasing direct ownership by 2% to 34,003 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 6d
  CEO, President Rodriguez Raul R covered exercise/tax liability with 2,424 shares, decreasing direct ownership by 0.86% to 279,593 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 6d
  EVP, GC, CCO & Corp Sec Furey Raymond J. covered exercise/tax liability with 877 shares, decreasing direct ownership by 2% to 50,936 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 12d
  Director Ali-Jackson Kamil sold $72,925 worth of shares (2,500 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 12,625 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 21d
  Director Wasman Jane was granted 5,750 shares, increasing direct ownership by 46% to 18,250 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 21d
  Director Moos Walter H was granted 5,750 shares, increasing direct ownership by 45% to 18,472 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 21d
  Director Miller Michael Patrick was granted 5,750 shares, increasing direct ownership by 3,075% to 5,937 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 21d
  Director Lapointe Anthony Gregg was granted 5,750 shares, increasing direct ownership by 46% to 18,250 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 21d
  Director Hannah Alison L. was granted 5,750 shares, increasing direct ownership by 54% to 16,375 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 21d
  Director Frohlich Mark W was granted 5,750 shares, increasing direct ownership by 460% to 7,000 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 21d
  Director Ali-Jackson Kamil was granted 5,750 shares, increasing direct ownership by 61% to 15,125 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 105d
  Director Moos Walter H exercised 4,000 shares at a strike of $24.00 and sold $145,440 worth of shares (4,000 units at $36.36) (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 110d
  CEO, President Rodriguez Raul R was granted 53,915 shares, increasing direct ownership by 24% to 282,017 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 110d
  EVP, Chief Medical Officer Rojkjaer Lisa was granted 18,894 shares, increasing direct ownership by 118% to 34,853 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 110d
  EVP, Chief Commercial Officer Santos David A was granted 19,430 shares, increasing direct ownership by 45% to 62,870 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 110d
  EVP & Chief Financial Officer Schorno Dean L was granted 20,636 shares, increasing direct ownership by 37% to 76,337 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 110d
  EVP, GC, CCO & Corp Sec Furey Raymond J. was granted 19,497 shares, increasing direct ownership by 60% to 51,813 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 117d
  EVP, Chief Medical Officer Rojkjaer Lisa covered exercise/tax liability with 3,758 shares, decreasing direct ownership by 19% to 15,959 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 117d
  CEO, President Rodriguez Raul R covered exercise/tax liability with 7,607 shares, decreasing direct ownership by 3% to 228,102 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 117d
  EVP, GC, CCO & Corp Sec Furey Raymond J. covered exercise/tax liability with 3,546 shares, decreasing direct ownership by 10% to 32,316 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 117d
  EVP, Chief Commercial Officer Santos David A covered exercise/tax liability with 3,546 shares, decreasing direct ownership by 8% to 43,440 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 117d
  EVP & Chief Financial Officer Schorno Dean L covered exercise/tax liability with 3,546 shares, decreasing direct ownership by 6% to 55,701 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 125d
  EVP, Chief Commercial Officer Santos David A covered exercise/tax liability with 5,718 shares, decreasing direct ownership by 11% to 46,986 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 125d
  EVP & Chief Financial Officer Schorno Dean L covered exercise/tax liability with 5,488 shares, decreasing direct ownership by 8% to 59,247 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 125d
  EVP, GC, CCO & Corp Sec Furey Raymond J. covered exercise/tax liability with 3,968 shares, decreasing direct ownership by 10% to 35,862 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 125d
  CEO, President Rodriguez Raul R exercised 80,000 shares at a strike of $27.40 and covered exercise/tax liability with 84,745 shares, decreasing direct ownership by 2% to 235,709 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 126d
  SEC Form 4 filed by Director Miller Michael Patrick

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 162d
  EVP & Chief Financial Officer Schorno Dean L exercised 6,500 shares at a strike of $21.51, increasing direct ownership by 11% to 64,235 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 265d
  SEC Form 4 filed by EVP & Chief Financial Officer Schorno Dean L

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 265d
  SEC Form 4 filed by EVP, Chief Commercial Officer Santos David A

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 265d
  SEC Form 4 filed by EVP, Chief Medical Officer Rojkjaer Lisa

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 265d
  SEC Form 4 filed by EVP, GC, CCO & Corp Sec Furey Raymond J.

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 265d
  SEC Form 4 filed by CEO, President Rodriguez Raul R

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 377d
  Director Wasman Jane was granted 2,500 shares, increasing direct ownership by 25% to 12,500 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 377d
  Director Ali-Jackson Kamil was granted 2,500 shares, increasing direct ownership by 36% to 9,375 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 377d
  Director Moos Walter H was granted 2,500 shares, increasing direct ownership by 24% to 12,722 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 377d
  Director Lapointe Anthony Gregg was granted 2,500 shares, increasing direct ownership by 25% to 12,500 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 377d
  Director Hannah Alison L. was granted 2,500 shares, increasing direct ownership by 31% to 10,625 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 377d
  Director Frohlich Mark W was granted 1,250 shares (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 447d
  SEC Form 4 filed by EVP & Chief Financial Officer Schorno Dean L

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 447d
  SEC Form 4 filed by EVP, Chief Commercial Officer Santos David A

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 447d
  SEC Form 4 filed by EVP, Chief Medical Officer Rojkjaer Lisa

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 447d
  SEC Form 4 filed by CEO, President Rodriguez Raul R

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 447d
  SEC Form 4 filed by EVP, GC, CCO & Corp Sec Furey Raymond J.

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 456d
  SEC Form 4 filed by Director Frohlich Mark W

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 488d
  EVP & Chief Financial Officer Schorno Dean L sold $80,615 worth of shares (3,770 units at $21.38), decreasing direct ownership by 6% to 57,235 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 488d
  EVP, Chief Commercial Officer Santos David A sold $83,836 worth of shares (3,921 units at $21.38), decreasing direct ownership by 7% to 51,704 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 488d
  CEO, President Rodriguez Raul R sold $200,075 worth of shares (9,352 units at $21.39), decreasing direct ownership by 4% to 239,454 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 488d
  EVP, GC, CCO & Corp Sec Furey Raymond J. sold $59,653 worth of shares (2,787 units at $21.40), decreasing direct ownership by 7% to 38,830 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 494d
  EVP, Chief Medical Officer Rojkjaer Lisa was granted 19,717 shares (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 494d
  CEO, President Rodriguez Raul R was granted 42,300 shares, increasing direct ownership by 20% to 248,806 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 494d
  EVP & Chief Financial Officer Schorno Dean L was granted 19,717 shares, increasing direct ownership by 48% to 61,005 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 494d
  EVP, Chief Commercial Officer Santos David A was granted 19,717 shares, increasing direct ownership by 55% to 55,625 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 494d
  EVP, GC, CCO & Corp Sec Furey Raymond J. was granted 19,717 shares, increasing direct ownership by 90% to 41,617 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 497d
  CEO, President Rodriguez Raul R exercised 90,000 shares at a strike of $21.40 and covered exercise/tax liability with 88,156 shares, increasing direct ownership by 0.90% to 206,506 units (SEC Form 4)

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 560d
  SEC Form 4 filed by EVP, Chief Commercial Officer Santos David A

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 560d
  SEC Form 4 filed by CEO, President Rodriguez Raul R

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)
• 560d
  SEC Form 4 filed by EVP & Chief Financial Officer Schorno Dean L

  4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)

Other RIGL categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends